238 related articles for article (PubMed ID: 18598891)
1. Lipoprotein(a), hormone replacement therapy, and risk of future cardiovascular events.
Suk Danik J; Rifai N; Buring JE; Ridker PM
J Am Coll Cardiol; 2008 Jul; 52(2):124-31. PubMed ID: 18598891
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.
Suk Danik J; Rifai N; Buring JE; Ridker PM
JAMA; 2006 Sep; 296(11):1363-70. PubMed ID: 16985228
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) and Cardiovascular Risk Prediction Among Women.
Cook NR; Mora S; Ridker PM
J Am Coll Cardiol; 2018 Jul; 72(3):287-296. PubMed ID: 30012322
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Disease, Mortality Risk, and Healthcare Costs by Lipoprotein(a) Levels According to Low-density Lipoprotein Cholesterol Levels in Older High-risk Adults.
Zhao Y; Delaney JA; Quek RG; Gardin JM; Hirsch CH; Gandra SR; Wong ND
Clin Cardiol; 2016 Jul; 39(7):413-20. PubMed ID: 27177347
[TBL] [Abstract][Full Text] [Related]
5. Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study.
Perrot N; Verbeek R; Sandhu M; Boekholdt SM; Hovingh GK; Wareham NJ; Khaw KT; Arsenault BJ
Atherosclerosis; 2017 Jan; 256():47-52. PubMed ID: 27998826
[TBL] [Abstract][Full Text] [Related]
6. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
[TBL] [Abstract][Full Text] [Related]
7. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.
Agarwala A; Pokharel Y; Saeed A; Sun W; Virani SS; Nambi V; Ndumele C; Shahar E; Heiss G; Boerwinkle E; Konety S; Hoogeveen RC; Ballantyne CM
Atherosclerosis; 2017 Jul; 262():131-137. PubMed ID: 28554015
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) levels and risk of abdominal aortic aneurysm in the Women's Health Initiative.
Chou EL; Pettinger M; Haring B; Mell MW; Hlatky MA; Wactawski-Wende J; Allison MA; Wild RA; Shadyab AH; Wallace RB; Snetselaar LG; Eagleton MJ; Conrad MF; Liu S
J Vasc Surg; 2021 Apr; 73(4):1245-1252.e3. PubMed ID: 32882349
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein apheresis for lipoprotein(a) and cardiovascular disease.
Moriarty PM; Gray JV; Gorby LK
J Clin Lipidol; 2019; 13(6):894-900. PubMed ID: 31753721
[TBL] [Abstract][Full Text] [Related]
10. [Lipoprotein (a) in a population-based study: more significant in Turkish women than men?].
Onat A; Yazici M; Hergenç G; Doğan Y; Karabulut A; Sari I; Türkmen S; Can G; Sansoy V
Anadolu Kardiyol Derg; 2005 Dec; 5(4):271-7. PubMed ID: 16330391
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
O'Donoghue ML; Fazio S; Giugliano RP; Stroes ESG; Kanevsky E; Gouni-Berthold I; Im K; Lira Pineda A; Wasserman SM; Češka R; Ezhov MV; Jukema JW; Jensen HK; Tokgözoğlu SL; Mach F; Huber K; Sever PS; Keech AC; Pedersen TR; Sabatine MS
Circulation; 2019 Mar; 139(12):1483-1492. PubMed ID: 30586750
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein(a) plasma levels, bone mineral density and risk of hip fracture: a post hoc analysis of the Women's Health Initiative, USA.
Haring B; Crandall CJ; Carbone L; Liu S; Li W; Johnson KC; Wactawski-Wende J; Shadyab AH; Gass ML; Kamensky V; Cauley JA; Wassertheil-Smoller S
BMJ Open; 2019 Apr; 9(4):e027257. PubMed ID: 31023762
[TBL] [Abstract][Full Text] [Related]
13. High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis.
Zhang W; Speiser JL; Ye F; Tsai MY; Cainzos-Achirica M; Nasir K; Herrington DM; Shapiro MD
J Am Coll Cardiol; 2021 Sep; 78(11):1083-1094. PubMed ID: 34503676
[TBL] [Abstract][Full Text] [Related]
14. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
[TBL] [Abstract][Full Text] [Related]
15. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
[TBL] [Abstract][Full Text] [Related]
16. An examination of the effect of combined cyclical hormone replacement therapy on lipoprotein(a) and other lipoproteins.
Haines CJ; Chung TK; Masarei JR; Tomlinson B; Lau JT
Atherosclerosis; 1996 Jan; 119(2):215-22. PubMed ID: 8808498
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium.
Waldeyer C; Makarova N; Zeller T; Schnabel RB; Brunner FJ; Jørgensen T; Linneberg A; Niiranen T; Salomaa V; Jousilahti P; Yarnell J; Ferrario MM; Veronesi G; Brambilla P; Signorini SG; Iacoviello L; Costanzo S; Giampaoli S; Palmieri L; Meisinger C; Thorand B; Kee F; Koenig W; Ojeda F; Kontto J; Landmesser U; Kuulasmaa K; Blankenberg S
Eur Heart J; 2017 Aug; 38(32):2490-2498. PubMed ID: 28449027
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular disease and Lp(a) in the adult population and in the elderly: the Brisighella study.
Nascetti S; D'Addato S; Pascarelli N; Sangiorgi Z; Grippo MC; Gaddi A
Riv Eur Sci Med Farmacol; 1996; 18(5-6):205-12. PubMed ID: 9177623
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 genotypes modulate the long-term effect of lipoprotein(a) on cardiovascular events: The Ioannina Study.
Naka KK; Bechlioullis A; Marini A; Sionis D; Vakalis K; Triantis G; Wilkins L; Rogus J; Kornman KS; Witztum JL; Doucette-Stamm L; Michalis LK; Tsimikas S
J Clin Lipidol; 2018; 12(2):338-347. PubMed ID: 29310992
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
